Do you want to read an article? Please log in or register.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: results from the global DISCOVER study programme
Type 2 Diabetes
COMMENTED
Related content
Further Publications
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated HbA1c (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Diabetes Obes Metab
Bonnet F, Chen H, Cooper A, Gomes MB, Ji L, Leigh P, Gutierrez LR, Shestakova MV, Shimomura I, Siddiqui A, Tang F, Vora J, Watada H, Khunti K
doi: 10.1111/dom.14476
COMMENTED
Type 2 Diabetes
Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
JAMA Netw Open.
O’Brien MJ, Karam SL, Wallia A, Kang RH, Cooper AJ, Lancki N, Moran MR, Liss DT, Prospect TA, Ackermann RT
doi: 10.1001/jamanetworkopen.
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.
COMMENTED
Type 2 DiabetesGlycemic Control
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ
doi: 10.2337/dci19-0066.
Glycemic Control
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c , body weight, quality of life, hypoglycaemic events, and glucose-lowering treatment intensification: the DISCOVER study
Diabetes Obes Metab
Khunti K, Charbonnel B, Cooper A, Gomes MB, Ji L, Leigh P, Nicolucci A, Rathmann W, Shestakova MV, Siddiqui A, Tang F, Watada H, Chen H, DISCOVER investigators.
doi: 10.1111/dom.14400
RECOMMENDED
Type 1 DiabetesType 2 DiabetesPediatric Diabetes
Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study
Diabetes Care.
Nip ASY, Reboussin BA, Dabelea D, Bellatorre A, Mayer-Davis EJ, Kahkoska AR, Lawrence JM, Peterson CM, Dolan L, Pihoker C, SEARCH for Diabetes in Youth Study Group
doi: 10.2337/dc18-2420.
COMMENTED
Type 1 DiabetesType 2 Diabetes
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J
doi: 10.1016/S2213-8587(20)30271-0.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Long-term sustainability of glycaemic achievements with second-line anti-diabetic therapies in patients with type 2 diabetes: A real-world study
Diabetes Obes Metab.
Montvida O, Shaw J, Blonde L, Paul SK
doi: 10.1111/dom.13288.